Réjean Thomas

R. Hogg, M. Loutfy, S. Walmsley, 2021, Journal of the Association of Medical Microbiology and Infectious Disease Canada = Journal officiel de l'Association pour la microbiologie medicale et l'infectiologie Canada.

Influence of NKG2C Genotypes on HIV Susceptibility and Viral Load Set Point

C. Tremblay, D. Rouleau, J. Routy, 2021, Journal of virology.

Cross-sectional comparison of age- and gender-related comorbidities in people living with HIV in Canada.

Réjean Thomas, J. Baril, A. Wong, 2022, Medicine.

Incidence of sexually transmitted infections before and after preexposure prophylaxis for HIV

H. Trottier, V. Nguyen, Réjean Thomas, 2017, AIDS.

A longitudinal view of successful aging with HIV: role of resilience and environmental factors

L. Fellows, N. Mayo, N. Dendukuri, 2021, Quality of Life Research.

Upregulation of IL-32 Isoforms in Virologically Suppressed HIV-Infected Individuals: Potential Role in Persistent Inflammation and Transcription From Stable HIV-1 Reservoirs.

S. Trottier, C. Tremblay, C. Chartrand-Lefebvre, 2019, Journal of acquired immune deficiency syndromes.

Impact of extended-release niacin on immune activation in HIV-infected immunological non-responders on effective antiretroviral therapy

J. Singer, J. Routy, M. Brouillette, 2020, HIV research & clinical practice.

The plasma levels of soluble ST2 as a marker of gut mucosal damage in early HIV infection

C. Tremblay, J. Routy, Réjean Thomas, 2016, AIDS.

Switch From Enfuvirtide to Raltegravir in Patients With Undetectable Viral Load: Efficacy and Safety at 24 Weeks in a Montreal Cohort

Réjean Thomas, R. Lalonde, N. Machouf, 2009, Journal of acquired immune deficiency syndromes.

‘You're only there on the phone’? A qualitative exploration of community, affect and agential capacity in HIV self‐testing using a smartphone app

N. Engel, A. Krumeich, K. Dheda, 2021, Sociology of health & illness.

Safety and Tolerability of Oral Cannabinoids in People Living with HIV on Long-Term ART: A Randomized, Open-Label, Interventional Pilot Clinical Trial (CTNPT 028)

A. Vigano, J. Routy, G. Sebastiani, 2022, Biomedicines.

CXCL13 as a Biomarker of Immune Activation During Early and Chronic HIV Infection

C. Tremblay, C. Chartrand-Lefebvre, J. Routy, 2019, Front. Immunol..

CXCL13 as a Biomarker of Immune Activation During Early and Chronic HIV Infection

C. Tremblay, C. Chartrand-Lefebvre, J. Routy, 2019, Front. Immunol..

Monkeypox in Montréal: Epidemiology, Phylogenomics, and Public Health Response to a Large North American Outbreak

M. Graham, D. Vinh, Réjean Thomas, 2022, Annals of Internal Medicine.

Effect of autogenic training on quality of life and symptoms in people living with HIV: A mixed method randomized controlled trial.

M. Brouillette, J. Côté, Réjean Thomas, 2022, Complementary therapies in clinical practice.

Circulating (1→3)-β-D-glucan Is Associated With Immune Activation During Human Immunodeficiency Virus Infection

C. Tremblay, C. Chartrand-Lefebvre, J. Routy, 2020 .

Circulating (1→3)-β-D-Glucan is associated with immune activation during HIV infection.

V. Martel-Laferrière, C. Tremblay, C. Chartrand-Lefebvre, 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Characterizing risk behaviour and reinfection rates for successful programs to engage core transmitters in HCV elimination (C-RESPECT)

B. Conway, G. Sebastiani, Réjean Thomas, 2021, Canadian liver journal.

Factors partitioning physical frailty in people aging with HIV: A classification and regression tree approach

L. Fellows, N. Mayo, M. Brouillette, 2022, HIV medicine.

Polyfunctional Fc Dependent Activity of Antibodies to Native Trimeric Envelope in HIV Elite Controllers

C. Tremblay, D. Rouleau, J. Routy, 2020, Frontiers in Immunology.

Adherence to Post-Exposure Prophylaxis (PEP) and Incidence of HIV Seroconversion in a Major North American Cohort

Réjean Thomas, D. Murphy, N. Machouf, 2015, PloS one.

Negligible Effect of Tenofovir on Atazanavir Trough Concentrations and Genotypic Inhibitory Quotients in the Presence and Absence of Ritonavir

Réjean Thomas, N. Sheehan, R. Lalonde, 2013, Therapeutic drug monitoring.

Immunosuppressive Tryptophan Catabolism and Gut Mucosal Dysfunction Following Early HIV Infection.

C. Tremblay, J. Routy, D. Radzioch, 2015, The Journal of infectious diseases.

Upregulated IL-32 Expression And Reduced Gut Short Chain Fatty Acid Caproic Acid in People Living With HIV With Subclinical Atherosclerosis

S. Gange, C. Tremblay, C. Chartrand-Lefebvre, 2021, Frontiers in Immunology.

Development of a G118R mutation in HIV-1 integrase following a switch to dolutegravir monotherapy leading to cross-resistance to integrase inhibitors.

M. Wainberg, B. Brenner, E. Martinez, 2016, The Journal of antimicrobial chemotherapy.

Selective resistance profiles emerging in patient-derived clinical isolates with cabotegravir, bictegravir, dolutegravir, and elvitegravir

C. Tremblay, B. Brenner, D. Rouleau, 2018, Retrovirology.

Proinflammatory isoforms of IL-32 as novel and robust biomarkers for control failure in HIV-infected slow progressors

S. Trottier, J. Singer, C. Kovacs, 2016, Scientific Reports.

Explaining the Presence of “Heterosexual” Female Clients of a Rapid HIV Testing Site Located in the Gay Village of Montreal, Quebec

Réjean Thomas, B. Lebouché, K. Engler, 2016, Journal of primary care & community health.

Changes in function of HIV-specific T-cell responses with increasing time from infection.

C. Tremblay, D. Rouleau, J. Routy, 2010, Viral immunology.

Human immunodeficiency virus (HIV)-specific effector CD8 T cell activity in patients with primary HIV infection.

D. Rouleau, J. Routy, G. Alter, 2002, The Journal of infectious diseases.

Kinetics of HIV-1 CTL Epitopes Recognized by HLA I Alleles in HIV-Infected Individuals at Times near Primary Infection: The Provir/Latitude45 Study

M. Wainberg, J. Routy, H. Fleury, 2014, PLoS ONE.

Evolution of Antibodies to Native Trimeric Envelope and Their Fc-Dependent Functions in Untreated and Treated Primary HIV Infection

C. Tremblay, D. Rouleau, J. Routy, 2021, Journal of virology.

Relative contribution of HIV-specific functional lymphocyte subsets restricted by protective and non-protective HLA alleles.

C. Tremblay, D. Rouleau, J. Routy, 2011, Viral immunology.

Receptor-Ligand Requirements for Increased NK Cell Polyfunctional Potential in Slow Progressors Infected with HIV-1 Coexpressing KIR3DL1*h/*y and HLA-B*57

C. Brander, C. Kovacs, S. Migueles, 2011, Journal of Virology.

High rates of forward transmission events after acute/early HIV-1 infection.

Michel Roger, M. Wainberg, C. Tremblay, 2007, The Journal of infectious diseases.

Natural Killer Cells from HIV Infected Slow Progressors Who Carry the Protective HLA-B * 27 Allele and Inhibitory KIR 3 DL 1 Receptors Have Elevated Poly-Functional Potential Compared to Bw 6 Homozygotes

C. Kovacs, S. Migueles, M. Connors, 2018 .

Natural Killer Cells from HIV Infected Slow Progressors Who Carry the Protective HLA-B*27 Allele and Inhibitory KIR3DL1 Receptors Have Elevated Poly-Functional Potential Compared to Bw6 Homozygotes

C. Kovacs, S. Migueles, M. Connors, 2011 .

Shifting the HIV Paradigm from Care to Cure: Proceedings from the Caribbean Expert Summit in Barbados, August 2017

V. Wilson, S. Vermund, T. Quinn, 2018, AIDS research and human retroviruses.

International Congress of Drug Therapy in HIV Infection 23-26 October 2016, Glasgow, UK

Raúl Tabarés Gutiérrez, Samit R. Joshi, H. Jessen, 2016, Journal of the International AIDS Society.

Chemsex and incidence of sexually transmitted infections among Canadian pre-exposure prophylaxis (PrEP) users in the l’Actuel PrEP Cohort (2013–2020)

M. Maheu-Giroux, Réjean Thomas, D. Panagiotoglou, 2022, Sexually Transmitted Infections.

Chemsex practices and pre-exposure prophylaxis (PrEP) trajectories among individuals consulting for PrEP at a large sexual health clinic in Montréal, Canada (2013-2020).

M. Maheu-Giroux, Réjean Thomas, D. Panagiotoglou, 2021, Drug and alcohol dependence.

Quantifying Anti-HIV Envelope-Specific Antibodies in Plasma from HIV Infected Individuals

C. Tremblay, D. Rouleau, J. Routy, 2019, Viruses.

International Congress of Drug Therapy in HIV Infection 2‐6 November 2014, Glasgow, UK

Samit R. Joshi, Charlene A Flash, Thomas Lengauer, 2014 .

Phenotypic characterization of single CD4+ T cells harboring genetically intact and inducible HIV genomes

J. Routy, B. Murrell, M. Massanella, 2023, Nature Communications.

Longitudinal Assessment of Changes in HIV-Specific Effector Activity in HIV-Infected Patients Starting Highly Active Antiretroviral Therapy in Primary Infection 1

D. Rouleau, B. Conway, J. Routy, 2003, The Journal of Immunology.

Antiretroviral Therapy in Primary Infection HIV-Infected Patients Starting Highly Active HIV-Specific Effector Activity in Longitudinal Assessment of Changes in Sékaly

D. Rouleau, B. Conway, J. Routy, 2003 .

Canadian guideline on HIV pre-exposure prophylaxis and nonoccupational postexposure prophylaxis

Lisa P. Barrett, I. Bogoch, C. Tremblay, 2017, Canadian Medical Association Journal.

Pre-exposure prophylaxis uptake among men who have sex with men who used non-occupational post-exposure prophylaxis: a longitudinal analysis of attendees at a large sexual health clinic in Montréal (Canada).

R. Milwid, M. Maheu-Giroux, Réjean Thomas, 2020, Journal of acquired immune deficiency syndromes.

Impact of Loneliness on Brain Health and Quality of Life Among Adults Living With HIV in Canada.

L. Fellows, N. Mayo, M. Brouillette, 2020, Journal of acquired immune deficiency syndromes.

Pre-exposure prophylaxis uptake among users of non-occupational post-exposure prophylaxis: a longitudinal analysis of attendees at a large sexual health clinic in Montréal

R. Milwid, M. Maheu-Giroux, Réjean Thomas, 2020 .

Tenofovir and Emtricitabine Resistance among Antiretroviral-Naive Patients in the Canadian Observational Cohort Collaboration: Implications for PrEP

R. Hogg, J. Montaner, A. Burchell, 2019, Antiviral therapy.

An analysis of socio-demographic and behavioural factors among immigrant MSM in Montreal from an HIV-testing site sample

Réjean Thomas, B. Lebouché, K. Engler, 2016 .

Explaining the appeal for immigrant men who have sex with men of a community-based rapid HIV-testing site in Montreal (Actuel sur Rue)

Réjean Thomas, B. Lebouché, K. Engler, 2015, AIDS care.

Past dynamics of HIV transmission among men who have sex with men in Montréal, Canada: a mathematical modeling study

T. Hart, R. Milwid, M. Boily, 2022, BMC Infectious Diseases.

Characteristics of new HIV diagnoses over 1995–2019: A clinic-based study in Montréal, Canada

M. Maheu-Giroux, Réjean Thomas, J. Szabo, 2021, PloS one.

P-01-066 PrEP in Montreal: good adherence, no seroconversion and no evidence of risk compensation

Réjean Thomas, N. Machouf, B. Trottier, 2016 .

Pre-exposure Prophylaxis Uptake Among Men Who Have Sex With Men Who Used nPEP: A Longitudinal Analysis of Attendees at a Large Sexual Health Clinic in Montréal (Canada).

R. Milwid, M. Maheu-Giroux, Réjean Thomas, 2020, Journal of acquired immune deficiency syndromes.

Quantifying cognition at the bedside: a novel approach combining cognitive symptoms and signs in HIV

L. Fellows, N. Mayo, L. Finch, 2015, BMC Neurology.

An Unsupervised Smart App–Optimized HIV Self-Testing Program in Montreal, Canada: Cross-Sectional Study

Krisztian G. Birkas, L. Joseph, Réjean Thomas, 2018, Journal of medical Internet research.

Treatment Switch to Dolutegravir With 2 Nucleoside Reverse-Transcriptase Inhibitors (NRTI) in Comparison to Continuation With Protease Inhibitor/Ritonavir Among Patients With Human Immunodeficiency Virus at Risk for Prior NRTI Resistance: A Cohort Analysis of Real-World Data

C. Tremblay, H. Trottier, Réjean Thomas, 2020, Open forum infectious diseases.

A mixed-method randomized feasibility trial evaluating progressive muscle relaxation or autogenic training on depressive symptoms and quality of life in people living with human immunodeficiency virus (HIV) who have depressive symptoms

M. Gagnon, M. Brouillette, J. Côté, 2020, Journal of complementary & integrative medicine.

Tobacco smoking and HIV-related immunologic and virologic response among individuals of the Canadian HIV Observational Cohort (CANOC)

R. Hogg, Nicanor Bacani, Réjean Thomas, 2021, AIDS care.

Relationships between cognition, function, and quality of life among HIV+ Canadian men

L. Fellows, N. Mayo, M. Brouillette, 2019, Quality of Life Research.

Factors associated with a decrease in the prevalence of drug resistance in newly HIV-1 infected individuals in Montreal

M. Wainberg, C. Tremblay, B. Brenner, 2004, AIDS.

Removing inactive NRTIs in a salvage regimen is safe, maintains virological suppression and reduces treatment costs: results from the VERITAS study (TMC114HIV4054)

Réjean Thomas, C. Costiniuk, M. Jenabian, 2015, HIV clinical trials.

Moments of Uncertainty

N. Engel, A. Krumeich, K. Dheda, 2021 .

The linkage-to-care, early retention, and description of HIV-positive clients at a rapid HIV-testing site in Montreal, Canada (Actuel sur Rue)

Réjean Thomas, B. Lebouché, K. Engler, 2017 .

Differential Impact of IL-32 Isoforms on the Functions of Coronary Artery Endothelial Cells: A Potential Link with Arterial Stiffness and Atherosclerosis

C. Tremblay, C. Chartrand-Lefebvre, J. Routy, 2023, Viruses.

Monkeypox in Montréal: Epidemiology, Phylogenomics, and Public Health Response to a Large North American Outbreak

M. Graham, D. Vinh, Réjean Thomas, 2022, Annals of Internal Medicine.

The role of extended-release niacin on immune activation and neurocognition in HIV-infected patients treated with antiretroviral therapy – CTN PT006: study protocol for a randomized controlled trial

J. Singer, J. Routy, M. Brouillette, 2014, Trials.

The process of learning the autogenic training relaxation technique and its benefits on the wellness of people living with HIV

M. Brouillette, J. Côté, Réjean Thomas, 2022, BMC Complementary Medicine and Therapies.

Influence of letermovir treatment on gut inflammation in people living with HIV on antiretroviral therapy: protocol of the open-label controlled randomised CIAO study

C. Tremblay, J. Routy, Réjean Thomas, 2023, BMJ Open.

Impact of previous HIV resistance and virologic failures on virologic outcome following a switch to dolutegravir with 2 NRTIs among people living with HIV

C. Tremblay, H. Trottier, Réjean Thomas, 2020, Medicine.

Effectiveness of a Web-Based Intervention to Support Medication Adherence Among People Living With HIV: Web-Based Randomized Controlled Trial

J. Côté, Réjean Thomas, J. Leblanc, 2020, JMIR public health and surveillance.

Recurrence of Human Papillomavirus External Genital Wart Infection Among High-Risk Adults in Montréal, Canada

Réjean Thomas, E. Rampakakis, M. Steben, 2017, Sexually transmitted diseases.

Time for HIV self-testing in Canada: a vision and an action plan

Réjean Thomas, N. Pai, 2020, Canadian Medical Association Journal.

Trends in Use of Combination Antiretroviral Therapy and Treatment Response from 2000 to 2016 in the Canadian Observational Cohort (CANOC): A Longitudinal Cohort Study.

R. Hogg, J. Montaner, M. Loutfy, 2022, The Canadian journal of hospital pharmacy.

Effect of antiretroviral therapy on HIV-1 genetic evolution during acute infection

C. Tremblay, A. Chamberland, D. Rouleau, 2011, International journal of STD & AIDS.

Switch From Enfuvirtide to Raltegravir in Patients With Undetectable Viral Load: Efficacy and Safety at 24 Weeks in a Montreal Cohort

Réjean Thomas, C. Torti, I. Izzo, 2009, Journal of acquired immune deficiency syndromes.

An Unsupervised Smart App–Optimized HIV Self-Testing Program in Montreal, Canada: Cross-Sectional Study

Krisztian G. Birkas, L. Joseph, Réjean Thomas, 2018, Journal of medical Internet research.

Development of a G118R mutation in HIV-1 integrase following a switch to dolutegravir monotherapy leading to cross-resistance to integrase inhibitors.

M. Wainberg, B. Brenner, E. Martinez, 2016, The Journal of antimicrobial chemotherapy.